Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses-Reference-Cited by-同舟云学术

Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses

Published:2013-01-29 Issue:6 Volume:68 Page:1237-1242
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:Journal of Antimicrobial Chemotherapy

Author:

Lambert-Niclot S.,Charpentier C.,Storto A.,Fofana D. B.,Soulie C.,Fourati S.,Visseaux B.,Wirden M.,Morand-Joubert L.,Masquelier B.,Flandre P.,Calvez V.,Descamps D.,Marcelin A.- G.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/68/6/1237/2286925/dkt003.pdf

Reference18 articles.

1. Antiretroviral Treatment of Adult HIV Infection

2. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults

3. Safety and Tolerance of Efavirenz in Different Antiretroviral Regimens: Results from a National Multicenter Prospective Study in 1,033 HIV-Infected Patients

4. Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic and antiretroviral drug resistance mutations analysis of reverse transcriptase and protease gene from Pakistani people living with HIV-1;PLOS ONE;2023-08-24

2. APOBEC3 selects V179I in HIV-1 reverse transcriptase to provide selective advantage for non-nucleoside reverse transcriptase inhibitor-resistant mutants;Frontiers in Virology;2022-07-14

3. Development of HIV Drug Resistance in a Cohort of Adults on First-Line Antiretroviral Therapy in Tanzania during the Stavudine Era;Microbiology Research;2021-11-12

4. Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients;Journal of Antimicrobial Chemotherapy;2021-05-20

5. Increasing Prevalence of HIV-1 Transmitted Drug Resistance in Portugal: Implications for First Line Treatment Recommendations;Viruses;2020-10-30